Immunovant News

Immunovant (IMVT) Gets a Buy From Piper Sandler

TipRanksApr 26 07:52 ET

Buy Rating Affirmed for Immunovant on Strong Drug Development Prospects and Efficacy Confidence

TipRanksApr 22 05:55 ET

Immunovant Analyst Ratings

BenzingaMar 28 06:48 ET

Immunovant Analyst Ratings

BenzingaMar 25 12:10 ET

Buy Rating for Immunovant Amidst Strong Market Position and Promising Batoclimab Trials

TipRanksMar 21 13:15 ET

Immunovant Analyst Ratings

BenzingaMar 13 08:36 ET

Immunovant Analyst Ratings

BenzingaFeb 20 06:30 ET

Immunovant Analyst Ratings

BenzingaFeb 15 06:38 ET

Buy Rating Affirmed on Immunovant's Promising Pipeline and Strategic Clinical Advancements

TipRanksFeb 15 01:16 ET

Analysts Are Bullish on Top Healthcare Stocks: Immunovant (IMVT), 4D Molecular Therapeutics (FDMT)

TipRanksFeb 13 06:20 ET

Buy Rating Affirmed on Immunovant Amidst Strategic Growth and Pipeline Strength

TipRanksFeb 13 05:03 ET

Immunovant (IMVT) Poised for Growth: A Buy Rating Backed by Strong Pipeline and Upcoming Catalysts

TipRanksFeb 13 04:59 ET

Immunovant's Buy Rating: Market Opportunities and Positive Trial Outcomes for Batoclimab

TipRanksFeb 5 15:55 ET

Stifel Nicolaus Keeps Their Buy Rating on Immunovant (IMVT)

TipRanksDec 25, 2023 21:05 ET

Analysts' Top Healthcare Picks: Hookipa Pharma (HOOK), Immunovant (IMVT)

TipRanksDec 25, 2023 00:40 ET

Stifel Nicolaus Sticks to Their Buy Rating for Immunovant (IMVT)

TipRanksDec 21, 2023 07:26 ET

Immunovant's Strong Phase 2 Results and Positive Outlook Prompt Buy Rating

TipRanksDec 21, 2023 06:56 ET

HC Wainwright & Co. Maintains Buy on Immunovant, Raises Price Target to $51

BenzingaDec 21, 2023 06:09 ET

Immunovant Analyst Ratings

BenzingaDec 21, 2023 06:09 ET

Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Immunovant (IMVT) and Henry Schein (HSIC)

TipRanksDec 21, 2023 06:00 ET